thiamine has been researched along with Multiple Sclerosis, Relapsing-Remitting in 1 studies
thiamine(1+) : A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively.
Multiple Sclerosis, Relapsing-Remitting: The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mallone, F | 1 |
| Lucchino, L | 1 |
| Franzone, F | 1 |
| Marenco, M | 1 |
| Carlesimo, SC | 1 |
| Moramarco, A | 1 |
1 other study available for thiamine and Multiple Sclerosis, Relapsing-Remitting
| Article | Year |
|---|---|
High-dose vitamin B supplementation for persistent visual deficit in multiple sclerosis: a pilot study.
Topics: Adult; Female; Humans; Male; Multiple Sclerosis, Relapsing-Remitting; Pilot Projects; Thiamine; Visi | 2020 |